selected publications
-
Journal Article
- Losartan improves memory, neurogenesis and cell motility in transgenic Alzheimer's mice. Pharmaceuticals (Basel, Switzerland). 2021
- Antifibrotic effects of amyloid-beta and Its loss in cirrhotic liver. Cells. 2020
- Cell motility and migration as determinants of stem cell efficacy. EBioMedicine. 2020
- Intranasal losartan decreases perivascular beta amyloid, inflammation, and the decline of neurogenesis in hypertensive rats. Neurotherapeutics. 2019
- Intranasal delivery of therapeutic neural stem cells to target intracerebral glioma 2015
- Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease. Cell Transplantation. 2014
- Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease 2011
- Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease 2010
-
Review
- Intranasal treatment of central nervous system dysfunction in humans [review]. Pharmaceutical Research. 2013